Endoscopic coverage of fetal myelomeningocele in utero.

OBJECTIVE Our goal was to evaluate the safety and efficacy of minimally invasive surgery for the coverage of myelomeningocele in utero. STUDY DESIGN Women in the mid-second trimester of a pregnancy complicated by fetal myelomeningocele were offered an experimental procedure designed to prevent ongoing exposure of the spinal cord to the intrauterine environment. The procedure consisted of maternal laparotomy while the patient was under both general and epidural anesthesia, with exposure of the gravid uterus. Endoscopic ports were placed for camera and operating instruments. Amniotic fluid was removed and replaced with carbon dioxide. The fetus was then positioned and a maternal split-thickness skin graft was placed over the exposed spinal cord or neural elements. The skin graft and a covering of Surgicel Absorbable Hemostat were attached with fibrin glue prepared from autologous cryoprecipitate. RESULTS Four fetuses with open myelomeningocele underwent endoscopic coverage of the spinal lesion between 22 weeks 3 days and 24 weeks 3 days of gestation. One infant, delivered by planned cesarean section at 35 weeks' gestation after demonstration of fetal lung maturity, is almost 3 years old. A second infant was delivered by cesarean section at 28 weeks after preterm labor and is now almost 6 months old. Both survivors manifest only mild motor and somatosensory deficits. One fetus who was delivered 1 week after operation after development of amnionitis died in the delivery room of extreme prematurity. The final fetus died intraoperatively from abruptio placentae. CONCLUSION Minimally invasive fetal surgery appears to constitute a feasible approach to nonlethal fetal malformations that result in progressive and disabling organ damage.

[1]  W. Warwick The unborn patient. , 1969, JAMA.

[2]  G M Hutchins,et al.  The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. , 1990, Neurosurgery.

[3]  W. Richards,et al.  A model for in utero endoscopic treatment of myelomeningocele. , 1993, Neurosurgery.

[4]  T. Lind,et al.  THE ROLE OF THE FETUS IN THE FORMATION OF AMNIOTIC FLUID , 1972, The Journal of obstetrics and gynaecology of the British Commonwealth.

[5]  G. Hutchins,et al.  Intrauterine repair of experimental surgically created dysraphism. , 1993, Neurosurgery.

[6]  G. Hutchins,et al.  Creation of myelomeningocele in utero: a model of functional damage from spinal cord exposure in fetal sheep. , 1995, Journal of pediatric surgery.

[7]  T. Lind,et al.  Relation of amniotic fluid volume to fetal weight in the first half of pregnancy. , 1970, Lancet.

[8]  G. Dawes THE AMNIOTIC FLUID , 1965, Developmental medicine and child neurology.

[9]  M. Michejda Intrauterine Treatment of Spina Bifida: Primate Model , 1984, Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood.

[10]  T. Lind,et al.  BIOCHEMICAL AND CYTOLOGICAL CHANGES IN LIQUOR AMNII WITH ADVANCING GESTATION , 1969, The Journal of obstetrics and gynaecology of the British Commonwealth.

[11]  R. Galask,et al.  Host-parasite interactions during pregnancy. , 1978, Obstetrical & gynecological survey.

[12]  Glynn Jp,et al.  Letter: paracetamol measurement. , 1975 .

[13]  A. Flake,et al.  The fetus as an optimal donor and recipient of hemopoietic stem cells. , 1992, Bone marrow transplantation.

[14]  J. Thorp,et al.  Epidural analgesia in labor and cesarean delivery for dystocia. , 1994, Obstetrical & gynecological survey.

[15]  F. Luks,et al.  Carbon dioxide pneumoamnios causes acidosis in fetal lamb. , 1994, Fetal diagnosis and therapy.

[16]  L D Edmonds,et al.  Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems. , 1996, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.